Health Information Technology Advisory Committee 2021 Schedule of Meetings, 47120-47121 [2021-18019]
Download as PDF
<![CDATA[
47120
Federal Register / Vol. 86, No. 160 / Monday, August 23, 2021 / Notices
Provider Relief Programs disbursed, and
are continuing to disburse, funds to
eligible healthcare providers through
two pathways: (1) Direct provider
payments via the PRF and ARPA–R
payments, and (2) claims
reimbursement via the CAF and the UIP.
This information collection includes
four components: (1) The PRF and
ARPA–R application portal; (2) the PRF
and ARPA–R attestation portal; (3) the
CAF application portal; and (4) the UIP
application portal. To date, information
for these programs has been collected
under a Paperwork Reduction Act
waiver executed pursuant to public
health emergency authorities. HRSA is
seeking comments regarding the CAF
and the UIP for the first time. These
information collections support
administration of the Provider Relief
Programs including the PRF, the
Uninsured Program, and the CAF (funds
for these three programs were
appropriated under the Coronavirus
Aid, Relief, and Economic Security Act
(Pub. L. 116–136), Paycheck Protection
Program and Health Care Enhancement
Act (Pub. L. 116–139), Coronavirus
Response and Relief Supplemental
Appropriations Act (Division M of Pub.
L. 116–260)), and the ARPA–R
payments (funds were appropriated
under the American Rescue Plan Act of
2021, Pub. L. 117–2).
Need and Proposed Use of the
Information: Providers who apply for
Provider Relief Programs (i.e., PRF,
ARPA–R, CAF, and UIP payments) must
apply for direct provider payments or
claims reimbursement and attest to a set
of Terms and Conditions to enable
HRSA’s appropriate disbursement and
oversight of recipients’ use of funds.
Information collected will allow for
(1) assessing if recipients have met
statutory and programmatic
requirements; (2) conducting audits; (3)
gathering data required to calculate,
disburse, and report on PRF, ARPA–R,
CAF, and UIP payments; and (4)
program evaluation. HRSA staff may
also use information collected to
identify and report on trends in the
effect of the COVID–19 pandemic on
health care providers and uninsured or
underinsured patients throughout the
United States.
HHS makes publicly available the
names of payment recipients and the
aggregate amounts received, for all
providers who attest to receipt of a
payment and acceptance of the Terms
and Conditions or who retain payments
for more than 90 days and are deemed
Number of
respondents
Form name
Average
burden per
response
(in hours)
Total
responses
Total burden
hours
Attestation Portal ..................................................................
Application Portal .................................................................
CAF Application ...................................................................
UIP Application ....................................................................
130,000
130,000
15,000
280,000
1
1
1
1
130,000
130,000
15,000
280,000
0.25
1.00
1.00
5.60
32,500
130,000
15,000
1,568,000
Total ..............................................................................
555,000
........................
555,000
........................
1,745,500
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions; (2) the accuracy of the
estimated burden; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2021–18018 Filed 8–20–21; 8:45 am]
jbell on DSKJLSW7X2PROD with NOTICES
Number of
responses per
respondent
to have accepted the Terms and
Conditions. By accepting funds, the
recipient consents to HHS publicly
disclosing the payments that recipient
has received.
Likely Respondents: Health care
providers that apply to receive, or have
applied to receive, PRF, ARPA–R, CAF,
or UIP payments, and attested to the
associated Terms and Conditions.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose, or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating, and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
Total Estimated Annualized Burden
Hours:
BILLING CODE 4165–15–P
VerDate Sep<11>2014
18:11 Aug 20, 2021
Jkt 253001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Information Technology
Advisory Committee 2021 Schedule of
Meetings
Office of the National
Coordinator for Health Information
Technology (ONC), HHS.
AGENCY:
ACTION:
Notice of meetings.
The Health Information
Technology Advisory Committee
(HITAC) was established in accordance
with the 21st Century Cures Act and the
Federal Advisory Committee Act. The
HITAC, among other things, identifies
priorities for standards adoption and
makes recommendations to the National
Coordinator for Health Information
Technology (National Coordinator). The
HITAC will hold public meetings
SUMMARY:
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
throughout 2021. See list of public
meetings below.
FOR FURTHER INFORMATION CONTACT:
Michael Berry, Designated Federal
Officer, at Michael.Berry@hhs.gov, (202)
701–0795.
Section
4003(e) of the 21st Century Cures Act
(Pub. L. 114–255) establishes the Health
Information Technology Advisory
Committee (referred to as the ‘‘HITAC’’).
The HITAC will be governed by the
provisions of the Federal Advisory
Committee Act (FACA) (Pub. L. 92–
463), as amended, (5 U.S.C. App.),
which sets forth standards for the
formation and use of federal advisory
committees.
SUPPLEMENTARY INFORMATION:
Composition
The HITAC is comprised of at least 25
members, of which:
E:\FR\FM\23AUN1.SGM
23AUN1
Federal Register / Vol. 86, No. 160 / Monday, August 23, 2021 / Notices
• November 10, 2021 from
approximately 9:30 a.m. to 2:30 p.m./
Eastern Time (virtual meeting)
All meetings are open to the public.
Additional meetings may be scheduled
as needed. For web conference
instructions and the most up-to-date
information, please visit the HITAC
calendar on the ONC website, https://
www.healthit.gov/topic/federaladvisory-committees/hitac-calendar.
Contact Person for Meetings: Michael
Berry, Michael.Berry@hhs.gov. A notice
in the Federal Register about last
minute modifications that impact a
previously announced advisory
committee meeting cannot always be
published quickly enough to provide
timely notice. Please email Michael
Berry for the most current information
about meetings.
Agenda: As outlined in the 21st
Century Cures Act, the HITAC will
develop and submit recommendations
to the National Coordinator on the
topics of interoperability, privacy and
security, and patient access. In addition,
the committee will also address any
administrative matters and hear
periodic reports from ONC. ONC
intends to make background material
Recommendations
available to the public no later than 24
The HITAC recommendations to the
hours prior to the meeting start time. If
National Coordinator are publicly
ONC is unable to post the background
available at https://www.healthit.gov/
material on its website prior to the
topic/federal-advisory-committees/
meeting, the material will be made
recommendations-national-coordinator- publicly available on ONC’s website
health-it.
after the meeting, at https://
www.healthit.gov/hitac.
Public Meetings
Procedure: Interested persons may
The schedule of meetings to be held
present data, information, or views,
in 2021 is as follows:
orally or in writing, on issues pending
• January 13, 2021 from approximately
before the committee. Written
9:30 a.m. to 2:30 p.m./Eastern Time
submissions may be made to the contact
(virtual meeting)
person prior to the meeting date. An
• February 10, 2021 from approximately oral public comment period will be
9:30 a.m. to 2:30 p.m./Eastern Time
scheduled at each meeting. Time
(virtual meeting)
allotted for each commenter will be
• March 10, 2021 from approximately
limited to three minutes. If the number
9:30 a.m. to 2:30 p.m./Eastern Time
of speakers requesting to comment is
(virtual meeting)
greater than can be reasonably
• April 15, 2021 from approximately
accommodated during the scheduled
9:30 a.m. to 2:30 p.m./Eastern Time
public comment period, ONC will take
(virtual meeting)
written comments after the meeting.
• May 13, 2021 from approximately
Persons attending in-person HITAC
9:30 a.m. to 2:30 p.m./Eastern Time
meetings are advised that the agency is
(virtual meeting)
• June 9, 2021 from approximately 9:30 not responsible for providing wireless
access or access to electrical outlets.
a.m. to 2:30 p.m./Eastern Time
ONC welcomes the attendance of the
(virtual meeting)
• July 14, 2021 from approximately 9:30 public at its HITAC meetings. Seating is
limited at in-person meetings, and ONC
a.m. to 2:30 p.m./Eastern Time
will make every effort to accommodate
(virtual meeting)
persons with physical disabilities or
• September 9, 2021 from
approximately 9:30 a.m. to 2:30 p.m./ special needs. If you require special
accommodations due to a disability,
Eastern Time (virtual meeting)
• October 13, 2021 from approximately please contact Michael Berry at least
seven (7) days in advance of the
9:30 a.m. to 2:30 p.m./Eastern Time
meeting.
(virtual meeting)
jbell on DSKJLSW7X2PROD with NOTICES
• No fewer than 2 members are
advocates for patients or consumers of
health information technology;
• 3 members are appointed by the
HHS Secretary
Æ 1 of whom shall be appointed to
represent the Department of Health and
Human Services and
Æ 1 of whom shall be a public health
official;
• 2 members are appointed by the
majority leader of the Senate;
• 2 members are appointed by the
minority leader of the Senate;
• 2 members are appointed by the
Speaker of the House of Representatives;
• 2 members are appointed by the
minority leader of the House of
Representatives; and
• Other members are appointed by
the Comptroller General of the United
States.
Members will serve for one-, two-, or
three-year terms. All members may be
reappointed for a subsequent three-year
term. Each member is limited to two
three-year terms, not to exceed six years
of service. Members serve without pay,
but will be provided per-diem and
travel costs for committee services, if
warranted.
VerDate Sep<11>2014
18:11 Aug 20, 2021
Jkt 253001
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
47121
Notice of these meetings are given
under the Federal Advisory Committee
Act (Pub. L. No. 92–463, 5 U.S.C., App.
2).
Dated: July 27, 2021.
Michael Berry,
Designated Federal Officer, Office of the
National Coordinator for Health Information
Technology.
[FR Doc. 2021–18019 Filed 8–20–21; 8:45 am]
BILLING CODE 4150–45–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; NIGMS Review of SuRE Applications.
Date: November 18, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Video Meeting).
Contact Person: Sonia Ortiz-Miranda,
Ph.D., Scientific Review Officer, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, 45 Center Drive, Room 3AN18,
Bethesda, MD 20892, (301) 402–9448,
sonia.ortiz-miranda@nih.gov.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; NIGMS Review of SuRE Applications.
Date: November 19, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Video Meeting).
Contact Person: Manas Chattopadhyay,
Ph.D., Scientific Review Officer, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, Building 45, Room 3AN12N, 45
Center Drive, Bethesda, MD 20892, 301–827–
5320, manasc@mail.nih.gov.
E:\FR\FM\23AUN1.SGM
23AUN1
]]>Agencies
[Federal Register Volume 86, Number 160 (Monday, August 23, 2021)]
[Notices]
[Pages 47120-47121]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-18019]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Information Technology Advisory Committee 2021 Schedule of
Meetings
AGENCY: Office of the National Coordinator for Health Information
Technology (ONC), HHS.
ACTION: Notice of meetings.
-----------------------------------------------------------------------
SUMMARY: The Health Information Technology Advisory Committee (HITAC)
was established in accordance with the 21st Century Cures Act and the
Federal Advisory Committee Act. The HITAC, among other things,
identifies priorities for standards adoption and makes recommendations
to the National Coordinator for Health Information Technology (National
Coordinator). The HITAC will hold public meetings throughout 2021. See
list of public meetings below.
FOR FURTHER INFORMATION CONTACT: Michael Berry, Designated Federal
Officer, at [email protected], (202) 701-0795.
SUPPLEMENTARY INFORMATION: Section 4003(e) of the 21st Century Cures
Act (Pub. L. 114-255) establishes the Health Information Technology
Advisory Committee (referred to as the ``HITAC''). The HITAC will be
governed by the provisions of the Federal Advisory Committee Act (FACA)
(Pub. L. 92-463), as amended, (5 U.S.C. App.), which sets forth
standards for the formation and use of federal advisory committees.
Composition
The HITAC is comprised of at least 25 members, of which:
[[Page 47121]]
No fewer than 2 members are advocates for patients or
consumers of health information technology;
3 members are appointed by the HHS Secretary
[cir] 1 of whom shall be appointed to represent the Department of
Health and Human Services and
[cir] 1 of whom shall be a public health official;
2 members are appointed by the majority leader of the
Senate;
2 members are appointed by the minority leader of the
Senate;
2 members are appointed by the Speaker of the House of
Representatives;
2 members are appointed by the minority leader of the
House of Representatives; and
Other members are appointed by the Comptroller General of
the United States.
Members will serve for one-, two-, or three-year terms. All members
may be reappointed for a subsequent three-year term. Each member is
limited to two three-year terms, not to exceed six years of service.
Members serve without pay, but will be provided per-diem and travel
costs for committee services, if warranted.
Recommendations
The HITAC recommendations to the National Coordinator are publicly
available at https://www.healthit.gov/topic/federal-advisory-committees/recommendations-national-coordinator-health-it.
Public Meetings
The schedule of meetings to be held in 2021 is as follows:
January 13, 2021 from approximately 9:30 a.m. to 2:30 p.m./
Eastern Time (virtual meeting)
February 10, 2021 from approximately 9:30 a.m. to 2:30 p.m./
Eastern Time (virtual meeting)
March 10, 2021 from approximately 9:30 a.m. to 2:30 p.m./
Eastern Time (virtual meeting)
April 15, 2021 from approximately 9:30 a.m. to 2:30 p.m./
Eastern Time (virtual meeting)
May 13, 2021 from approximately 9:30 a.m. to 2:30 p.m./Eastern
Time (virtual meeting)
June 9, 2021 from approximately 9:30 a.m. to 2:30 p.m./Eastern
Time (virtual meeting)
July 14, 2021 from approximately 9:30 a.m. to 2:30 p.m./
Eastern Time (virtual meeting)
September 9, 2021 from approximately 9:30 a.m. to 2:30 p.m./
Eastern Time (virtual meeting)
October 13, 2021 from approximately 9:30 a.m. to 2:30 p.m./
Eastern Time (virtual meeting)
November 10, 2021 from approximately 9:30 a.m. to 2:30 p.m./
Eastern Time (virtual meeting)
All meetings are open to the public. Additional meetings may be
scheduled as needed. For web conference instructions and the most up-
to-date information, please visit the HITAC calendar on the ONC
website, https://www.healthit.gov/topic/federal-advisory-committees/hitac-calendar.
Contact Person for Meetings: Michael Berry, [email protected].
A notice in the Federal Register about last minute modifications that
impact a previously announced advisory committee meeting cannot always
be published quickly enough to provide timely notice. Please email
Michael Berry for the most current information about meetings.
Agenda: As outlined in the 21st Century Cures Act, the HITAC will
develop and submit recommendations to the National Coordinator on the
topics of interoperability, privacy and security, and patient access.
In addition, the committee will also address any administrative matters
and hear periodic reports from ONC. ONC intends to make background
material available to the public no later than 24 hours prior to the
meeting start time. If ONC is unable to post the background material on
its website prior to the meeting, the material will be made publicly
available on ONC's website after the meeting, at https://www.healthit.gov/hitac.
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person prior to the
meeting date. An oral public comment period will be scheduled at each
meeting. Time allotted for each commenter will be limited to three
minutes. If the number of speakers requesting to comment is greater
than can be reasonably accommodated during the scheduled public comment
period, ONC will take written comments after the meeting.
Persons attending in-person HITAC meetings are advised that the
agency is not responsible for providing wireless access or access to
electrical outlets.
ONC welcomes the attendance of the public at its HITAC meetings.
Seating is limited at in-person meetings, and ONC will make every
effort to accommodate persons with physical disabilities or special
needs. If you require special accommodations due to a disability,
please contact Michael Berry at least seven (7) days in advance of the
meeting.
Notice of these meetings are given under the Federal Advisory
Committee Act (Pub. L. No. 92-463, 5 U.S.C., App. 2).
Dated: July 27, 2021.
Michael Berry,
Designated Federal Officer, Office of the National Coordinator for
Health Information Technology.
[FR Doc. 2021-18019 Filed 8-20-21; 8:45 am]
BILLING CODE 4150-45-P
